FDA Aims To Boost Inspections Of Foreign Drugmakers

Law360, New York (February 1, 2012, 5:23 PM EST) -- The U.S. Food and Drug Administration's commissioner told congressional lawmakers on Wednesday the agency seeks to dramatically ramp up foreign inspections to monitor the safety of a growing number of drugs and drug ingredients flowing to the U.S. from abroad.

At a U.S. House of Representatives panel hearing, FDA Commissioner Margaret Hamburg took on criticism that the agency sends inspectors to scrutinize drug manufacturing operations in the U.S. every two years, while subjecting pharmaceutical companies in India, China and other foreign countries that produce drugs for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.